Focus: Oticon is a 120-year-old Danish hearing aid and implant manufacturer with 5,000+ employees, specializing in bone-anchored hearing aids, cochlear implants, and sound processing technologies for conductive and sensorineural hearing loss.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Oticon to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship product line with multiple generations (Ponto 3, Ponto 4, Ponto Wide) and minimally invasive surgical options; core revenue driver.
Help build intelligence for Oticon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Oticon's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Next-generation fully implantable bone conduction system with post-market pediatric and adolescent expansion; represents technology advancement in implantable hearing aids.
Cochlear implant offering with proprietary XDP sound processing strategy; addresses severe-to-profound sensorineural hearing loss.
Software-based sound processing innovation enabling real-world speech recognition and noise reduction; differentiator across device portfolio.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub